Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 1/2019

04.09.2018

Eligibility of cardiac resynchronization therapy patients for subcutaneous implantable cardioverter defibrillators

verfasst von: Massimo Giammaria, Maria Teresa Lucciola, Claudia Amellone, Fabrizio Orlando, Giuseppe Mazzone, Sara Chiarenza, Mariolina Lovecchio, Sergio Valsecchi

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Before subcutaneous implantable cardioverter defibrillator (S-ICD) implantation, the adequacy of sensing is required to be verified through surface ECG screening. Our objective was to determine whether S-ICD can be considered as a supplementary therapy in patients who are receiving biventricular (BIV) pacing.

Methods

We evaluated 48 patients with BIV devices to determine S-ICD candidacy during BIV, left ventricular (LV), right ventricular (RV) pacing, and intrinsic conduction (left bundle branch block—LBBB) by using an automated screening tool. Eligibility was defined by the presence of at least one appropriate vector in the supine and standing positions.

Results

Eligibility was verified during BIV pacing in 34 (71%) patients. In patients screened-out, QRS duration was longer (p = 0.035) and ischemic cardiomyopathy was more frequent (p = 0.027). LV-only pacing was associated with a lower passing rate (46%) (p < 0.001 versus BIV). The LBBB QRS morphology during inhibited ventricular pacing was acceptable in 51% of patients. The QRS generated by RV pacing was acceptable in 25% of patients. In patients who passed the screening test during BIV, the QRS was not acceptable in 76% during RV pacing (i.e., accidental loss of LV capture). The concomitant adequacy during inhibited ventricular pacing (i.e., possible intrinsic conduction) was not assessed in 40% of patients.

Conclusions

S-ICD may be a supplemental therapy in the majority of CRT patients. Standard BIV pacing should be preferred to the LV-only pacing mode, as it is more frequently associated with adequacy of S-ICD sensing. Spontaneous LBBB and RV-paced QRS morphologies are frequently inadequate. Therefore, in patients selected for concomitant S-ICD and CRT implantation, accidental loss of LV capture or possible intrinsic conduction must be prevented.
Literatur
1.
Zurück zum Zitat Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17:1601–87.PubMed Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the Management of Patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 2015;17:1601–87.PubMed
2.
Zurück zum Zitat Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.CrossRefPubMed Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944–53.CrossRefPubMed
3.
Zurück zum Zitat Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, et al. Evaluation of early complications related to De novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774–82.CrossRefPubMed Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, et al. Evaluation of early complications related to De novo cardioverter defibrillator implantation insights from the Ontario ICD database. J Am Coll Cardiol. 2010;55:774–82.CrossRefPubMed
4.
Zurück zum Zitat Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493–7.CrossRefPubMedPubMedCentral Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493–7.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for Management of Patients with Ventricular Arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2017;(2017 Oct 30) Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for Management of Patients with Ventricular Arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2017;(2017 Oct 30)
6.
Zurück zum Zitat Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, et al. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol. 2017;70:830–41.CrossRefPubMed Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, et al. Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J Am Coll Cardiol. 2017;70:830–41.CrossRefPubMed
7.
Zurück zum Zitat Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553–61.CrossRefPubMed Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122:1553–61.CrossRefPubMed
8.
Zurück zum Zitat Haugaa KH, Tilz R, Boveda S, Dobreanu D, Sciaraffia E, Mansourati J, et al. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European heart rhythm association survey. Europace. 2017;19:660–4.CrossRefPubMed Haugaa KH, Tilz R, Boveda S, Dobreanu D, Sciaraffia E, Mansourati J, et al. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European heart rhythm association survey. Europace. 2017;19:660–4.CrossRefPubMed
9.
Zurück zum Zitat Perego GB, Chianca R, Facchini M, Frattola A, Balla E, Zucchi S, et al. Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study. Eur J Heart Fail. 2003;5:305–13.CrossRefPubMed Perego GB, Chianca R, Facchini M, Frattola A, Balla E, Zucchi S, et al. Simultaneous vs. sequential biventricular pacing in dilated cardiomyopathy: an acute hemodynamic study. Eur J Heart Fail. 2003;5:305–13.CrossRefPubMed
10.
Zurück zum Zitat Olde Nordkamp LR, Warnaars JL, Kooiman KM, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25:494–9.CrossRefPubMed Olde Nordkamp LR, Warnaars JL, Kooiman KM, et al. Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening. J Cardiovasc Electrophysiol. 2014;25:494–9.CrossRefPubMed
11.
Zurück zum Zitat Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014;16:1015–21.CrossRefPubMed Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Europace. 2014;16:1015–21.CrossRefPubMed
12.
Zurück zum Zitat Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361–6.CrossRefPubMed Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, et al. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361–6.CrossRefPubMed
13.
Zurück zum Zitat Ip JE, Wu MS, Kennel PJ, et al. Eligibility of pacemaker patients for subcutaneous implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2017;28:544–8.CrossRefPubMed Ip JE, Wu MS, Kennel PJ, et al. Eligibility of pacemaker patients for subcutaneous implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2017;28:544–8.CrossRefPubMed
14.
Zurück zum Zitat Theuns DA, Burke M, Allavatam V, et al. AB05–01: evaluation of a high pass filter designed to reduce oversensing in the S-ICD (abstr.). Heart Rhythm. 2016;13:S10–1.CrossRef Theuns DA, Burke M, Allavatam V, et al. AB05–01: evaluation of a high pass filter designed to reduce oversensing in the S-ICD (abstr.). Heart Rhythm. 2016;13:S10–1.CrossRef
15.
Zurück zum Zitat Olde Nordkamp LR, Brouwer TF, Barr C, et al. Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. Int J Cardiol. 2015;195:126–33.CrossRefPubMed Olde Nordkamp LR, Brouwer TF, Barr C, et al. Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management. Int J Cardiol. 2015;195:126–33.CrossRefPubMed
16.
Zurück zum Zitat Willcox ME, Prutkin JM, Bardy GH. Recent developments in the subcutaneous ICD. Trends Cardiovasc Med. 2016;26:526–35.CrossRefPubMed Willcox ME, Prutkin JM, Bardy GH. Recent developments in the subcutaneous ICD. Trends Cardiovasc Med. 2016;26:526–35.CrossRefPubMed
17.
Zurück zum Zitat Hernández-Madrid A, Facchin D, Klepfer RN, Ghosh S, Matía R, Moreno J, et al. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for efficacy analysis of CRT (OLÉ CRT) study. Heart Rhythm. 2017;14:541–7.CrossRefPubMed Hernández-Madrid A, Facchin D, Klepfer RN, Ghosh S, Matía R, Moreno J, et al. Device pacing diagnostics overestimate effective cardiac resynchronization therapy pacing results of the hOLter for efficacy analysis of CRT (OLÉ CRT) study. Heart Rhythm. 2017;14:541–7.CrossRefPubMed
18.
Zurück zum Zitat Okamura H, McLeod CJ, DeSimone CV, et al. Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease. Circ J. 2016;80:1328–35.CrossRefPubMed Okamura H, McLeod CJ, DeSimone CV, et al. Right parasternal lead placement increases eligibility for subcutaneous implantable cardioverter defibrillator therapy in adults with congenital heart disease. Circ J. 2016;80:1328–35.CrossRefPubMed
19.
Zurück zum Zitat Santini L, Pappalardo A, Schirripa V, Danisi N, Forleo GB, Ammirati F. Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators. HeartRhythm Case Rep. 2017;3:286–8.CrossRefPubMedPubMedCentral Santini L, Pappalardo A, Schirripa V, Danisi N, Forleo GB, Ammirati F. Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators. HeartRhythm Case Rep. 2017;3:286–8.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Tjong FV, Brouwer TF, Smeding L, et al. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace. 2016;18:1740–7.CrossRefPubMed Tjong FV, Brouwer TF, Smeding L, et al. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance. Europace. 2016;18:1740–7.CrossRefPubMed
Metadaten
Titel
Eligibility of cardiac resynchronization therapy patients for subcutaneous implantable cardioverter defibrillators
verfasst von
Massimo Giammaria
Maria Teresa Lucciola
Claudia Amellone
Fabrizio Orlando
Giuseppe Mazzone
Sara Chiarenza
Mariolina Lovecchio
Sergio Valsecchi
Publikationsdatum
04.09.2018
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 1/2019
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-018-0437-9

Weitere Artikel der Ausgabe 1/2019

Journal of Interventional Cardiac Electrophysiology 1/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.